Carolene Therapeutics Private Limited

Carolene Therapeutics Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100PN2020PTC191871 Incorporated 11 July 2020 ROC Pune HQ Aurangabad, Maharashtra, India
Active Private Limited Company pharma Startup India MSME · Micro
Revenue · FY 2024
₹2.43 Lakh
▼ 54% YoY
Net loss · FY 2024
₹3.81 Lakh
Net margin -156.5%
EBITDA · FY 2024
-₹3.67 Lakh
EBITDA margin -150.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Carolene Therapeutics Private Limited

Data last updated:

Carolene Therapeutics Private Limited is a private limited company based in Aurangabad, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 July 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2020PTC191871. Its GSTIN is 27AAICC8055C1ZP (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shivanand Arjun Mante and Amit Gajanan Nerkar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. 25 S. No. A1 1st Floor Chinar Arcade Padegaon, Aurangabad, Maharashtra, India – 431001.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.43 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net loss of ₹3.81 Lakh (net margin -156.5%) and EBITDA of -₹3.67 Lakh (EBITDA margin -150.9%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years.

Carolene Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0043749).

Company details

CIN U24100PN2020PTC191871
Registration Number 191871
Incorporation Date 11 July 2020
ROC Pune
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0043749

Recognitions & Rankings of Carolene Therapeutics

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-04-0043749

Contact details

Carolene Therapeutics Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No. 25 S. No. A1 1st Floor Chinar Arcade Padegaon, Aurangabad, Maharashtra, India – 431001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Carolene Therapeutics Private Limited, buy the company report.

Comprehensive company report
Carolene Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Carolene Therapeutics is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Carolene Therapeutics Private Limited, buy the company report.

Financials of Carolene Therapeutics Private Limited

FY 2024 filings available

Carolene Therapeutics Private Limited reported revenue of ₹2.43 Lakh (down 54% YoY) for FY 2024.

Revenue · FY 2024
₹2.43 Lakh ▼ 54%
Net loss · FY 2024
₹3.81 Lakh margin -156.5%
EBITDA · FY 2024
-₹3.67 Lakh margin -150.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 54%
3 years · compounded
▲ 59%
EBITDA CAGR growth
1 year
▼ 90%

Revenue fell 54% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 59%. EBITDA fell 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.67 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹3.81 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-150.9%
Net Profit Margin-156.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Carolene Therapeutics Private Limited, buy the company report.

Board of directors of Carolene Therapeutics Private Limited

Carolene Therapeutics has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shivanand Arjun ManteDirector11 Jul 20206 Years 4 MonthsCurrent
Amit Gajanan NerkarDirector11 Jul 20206 Years 4 MonthsCurrent

Auditor

Carolene Therapeutics Private Limited is audited by KAJALE AND ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
KAJALE AND ASSOCIATESFY 2022137161W

Shareholding

The shareholding of Carolene Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Carolene Therapeutics Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Carolene Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Carolene Therapeutics Private Limited has 1 active EPFO establishment as of Nov 11, 2026.

Active EPFO establishments
1

GST

Carolene Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAICC8055C1ZPMaharashtraActive11 Dec 2020

To see the full GST registrations and return filing status of Carolene Therapeutics Private Limited, buy the company report.

Recent activity

Carolene Therapeutics Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Amit Gajanan Nerkar was appointed as Director on 11 Jul 2020.

AGM
Carolene Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Carolene Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Appointed
Amit Gajanan Nerkar was appointed as Director.
Appointed
Shivanand Arjun Mante was appointed as Director.
Incorporation
11 Jul 2020
Carolene Therapeutics Private Limited was registered on 11 Jul 2020 with Roc Pune & aged 6 years 4 months as per MCA records.

Frequently asked questions

Carolene Therapeutics is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 July 2020 (6+ years old) and is registered under CIN U24100PN2020PTC191871.

Carolene Therapeutics has 2 current directors:

The latest financial statements of Carolene Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Carolene Therapeutics is 27AAICC8055C1ZP, registered in Maharashtra.

The CIN (Corporate Identification Number) of Carolene Therapeutics is U24100PN2020PTC191871. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Carolene Therapeutics was incorporated on 11 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.

Amit Gajanan Nerkar was appointed as Director on 11 Jul 2020. Shivanand Arjun Mante was appointed as Director on 11 Jul 2020.

Yes, Carolene Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Carolene Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0043749).

The registered office of Carolene Therapeutics is at Shop No. 25 S. No. A1 1st Floor Chinar Arcade Padegaon, Aurangabad, Maharashtra, India – 431001.